Skip to content

Comparative evaluation of two motivational methods performed during Periodontal Treatment in patients with Gingival Disease

Comparative evaluation of two motivation programs carried out during Therapy Basic Periodontal disease in patients with Gingival and Periodontal Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4wt3h7
Enrollment
Unknown
Registered
2020-05-28
Start date
2016-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic periodontitis

Interventions

The sample will be composed of systemically healthy patients who are diagnosed with gingival and periodontal disease and in need of basic periodontal therapy. An sample with 26 patients. After anamnes
patients over 18 years of age and under 65 years of age
patients able to read and sign the IC
patients diagnosed with periodontal disease and in need of basic periodontal therapy
patients who have access to an instant messaging application (WhatsApp). Exclusion criteria: Patients with any pathology that negatively influences tissue healing (eg diabetes melitus)
patients using any drugs that negatively influence the oral environment
pregnant and nursing patients
patients with chronic renal failure
patients with advanced liver disease (eg, cirrhosis)
patients with decompensated hypertension or an inc
Behavioural
Other

Sponsors

Centro de Estudos Superiores de Maceió
Lead Sponsor
Centro de Estudos Superiores de Maceió
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Systemically healthy patients; patients over 18 years of age and under 65 years; patients able to read and sign the IC; patients diagnosed with periodontal disease and in need of basic periodontal therapy; patients who have access to an instant messaging application (WhatsApp).

Exclusion criteria

Exclusion criteria: Patients with any pathology that negatively influences tissue healing (eg diabetes melitus); patients using any drugs that negatively influence the oral environment; pregnant and nursing patients; patients with chronic renal failure; patients with advanced liver disease (eg, cirrhosis); patients with decompensated hypertension or an increased risk of cardiovascular disease.

Design outcomes

Primary

MeasureTime frame
A survey was carried out in which 26 volunteers, of both genders, were included. 20 women and 6 men. The age of the volunteers was between 21 and 59 years. The volunteers were allocated to two groups A and B. Where 13 patients were in group A and 13 patients in group B. It can be seen in the table above that there was significant improvement (G test, p = 0.0236) in 62% of the cases. of the motivation group in relation to the control group, which showed improvement in only 23.1% of the patients. This could be seen clinically, so that in the control group, of the 13 patients, 7 improved the SI and 5 improved the BI, while in the motivation group of 13 patients, only 1 did not improve the SI, 9 improved the BI. As for the diagnosis, in the control group, of the 13 patients, 3 improved, 9 remained in the same group and 1 got worse. Compared to the motivation group, there are clinical differences between the groups, whereas, of the 13 patients, 8 achieved improvement, including 1 patient who reached health status and only 5 remained in the same diagnosis. It was possible to observe that there were no statistically significant differences (two-way ANOVA, p> 0.05) between groups or between periods for bleeding (p = 0.67), biofilm (p = 0.58) and bag (p = 0.44). However, there was a relevant clinical improvement for the majority of patients in both groups, being more noticeable among patients who were subjected to a special motivation. Likewise, there were no statistically significant differences (two-way ANOVA, p> 0.05) between the groups for PSV (p = 0.68), PMG (p = 0.68) and NIC (p = 0.85). Taking into account that the time for reevaluation of patients with gingivitis was 21 days and that of patients with periodontitis was 45 days, it is clear that a longer time between reevaluations is necessary for there to be a more substantial result with regard to clinical parameters PSV, PMG and NIC. The effect of treatments on the number of bags at their different depths is shown i

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactNatália de Andrade

Centro de Estudos Superiores de Maceió

karol.andrade.odonto@hotmail.com+55-082-988651926

Outcome results

None listed

Source: REBEC (via WHO ICTRP)